Global Neurodegenerative Disease Market Growth, Trends, and Forecast 2023-2033

The Global Neurodegenerative Disease Market Size is Anticipated to Exceed USD 90.10 Billion by 2033, Growing at a CAGR of 7.84% from 2023 to 2033. Neurodegenerative diseases are a group of disorders characterized by the progressive degeneration of nerve cells (neurons) in the brain and nervous system. Over time, this leads to a decline in cognitive functions, motor skills, and overall brain activity. Common neurodegenerative diseases include Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), and Huntington's disease. These conditions are often chronic and worsen over time, with no known cures, although treatments may help manage symptoms or slow progression. The neurodegenerative disease market is expanding rapidly, driven by the increasing prevalence of these conditions due to aging populations and advances in medical research. Ongoing innovations, such as gene therapies, biologics, and disease-modifying treatments, are key drivers in this market.